Judge Orders FDA To Approve Watson's Generic Actos

Law360, New York (October 22, 2012, 4:42 PM EDT) -- A Washington federal judge on Monday ordered the U.S. Food and Drug Administration to immediately approve Watson Laboratories Inc.'s generic version of Takeda North America Inc. diabetes drug Actos, after Watson accused the FDA of attempting to rob it of a 180-day marketing exclusivity period.

In a one-page order, U.S. District Judge Amy Berman Jackson granted Watson's summary judgment motion and ordered the FDA to immediately approve the generics maker's abbreviated new drug application for generic Actos, “so that Watson Laboratories may participate in what remains...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

WATSON LABORATORIES, INC. v. SEBELIUS et al


Case Number

1:12-cv-01344

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Judge

Amy Berman Jackson

Date Filed

August 15, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.